Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: J Surg Oncol. 2011 Oct 17;105(6):601–605. doi: 10.1002/jso.22115

TABLE II.

Proportion of Patients With Lymph Node Dissections by Underlying Characteristics

Patient characteristic No lymph node dissection (n = 127) Lymph node dissection (n = 7) P-value
Male gender 20 (15.8%) 3 (42.9%) 0.064
Non-White race 22 (17.6%) 1 (14.3%) 0.882
Positive family history 7 (5.6%) 0 (0.0%) 0.522
History of radiation 8 (6.4%) 1 (14.3%) 0.416
History of thyroiditis 34 (27.4%) 2 (28.6%) 0.947
Palpable nodule 96 (76.2%) 7 (100.0%) 0.142
Palpable lymph nodes 1 (0.8%) 0 (0.0%) 0.813
Ultrasound focality 74 (58.3%) 4 (57.1%) 0.953
Microcalcifications 25 (2.02%) 4 (57.1%) 0.022*
Hypervascularity 30 (24.4%) 0 (0.0%) 0.136
Mean size in cm (ultrasound) 2.27 (SD = 1.36) 2.46 (SD = 1.29) 0.722
Thyroid function 0.854
 Hypothyroid 31 (25.0%) 2 (28.6%)
 Euthyroid 88 (71.0%) 5 (71.4%)
 Hyperthyroid 5 (4.0%) 0 (0.0%)
FNAB category of nodule 0.002*
 Suspicious 32 (25.2%) 6 (85.7%)
 Follicular neoplasm 42 (33.1%) 0 (0.0%)
 ACUS 53 (41.7%) 1 (14.3%)

SD, standard deviation; ACUS, atypical cells of undetermined significance.

*

Statistically significant.